# BIMI Holdings Inc. (BIMI)

> Source: Nexqual · https://nexqual.com/BIMI · data as of 2026-10-23 20:00 UTC · cite as "Nexqual, BIMI Holdings Inc. (BIMI), nexqual.com/BIMI" · informational, not investment advice.

**Price:** USD 0 (+0.00% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 0 · day 0–0 · 52w 0–0 · market cap $6K · PNK

## Key facts
- Analysts: None.
- Total return with dividends: 1Y +300.0% vs S&P 500 +13.4%; 5Y -100.0% vs S&P 500 +76.9%.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +300.0% | -100.0% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +301.9% | -90.1% |
| Volatility (annualized) | 333.7% | 277.9% |
| Max drawdown | -80.0% (Sep 2026→Oct 2026) | -100.0% (Nov 2021→Jan 2025) |

## Peers (Pharmaceutical Retailers)
BDX (Becton, Dickinson and Company) USD 198.91 -0.75% · ARGX (argenx SE) USD 873.71 -0.23% · CAH (Cardinal Health, Inc.) USD 249.57 -2.37% · NTRA (Natera, Inc.) USD 403.95 +0.64% · COR (Cencora, Inc.) USD 331 -2.21% · TAK (Takeda Pharmaceutical Company L) USD 20.24 -0.59%

## More
Full page: https://nexqual.com/BIMI · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2011-09-30) | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year (ends 2011-12-31) | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |